Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.

In order to compare the clinical and microbiological efficacies and safety of piperacillin plus tazobactam with those of imipenem plus cilastatin, 134 patients with intra-abdominal infections (73 patients with appendicitis) participated in an open randomized comparative multicenter trial. A total of...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Brismar, B, Malmborg, A S, Tunevall, G, Wretlind, B, Bergman, L, Mentzing, L O, Nyström, P O, Kihlström, E, Bäckstrand, B, Skau, T
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1992
Materias:	Research Article
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245542/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1336347/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.12.2766
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!